The National Institutes of Health (NIH) announces National Biosafety Stewardship Month
ASM commented on an FDA proposal to reclassify antigen based rapid influenza virus antigen detection test systems intended to detect influenza virus directly from clinical specimens.
The ASM has prepared a history related to select agents.
The ASM sent a statement to ASM members on Dual Use Research of Concern and Biosafety.
The ASM sent a letter to Senator Tom Harkin thanking him for the Accelerating Biomedical Research Act and his leadership regarding funding for the National Institutes of Health.